Johnson & Johnson is planning to invest more than $2 billion to develop a new pharmaceutical manufacturing campus in North Carolina that would allow it to tap into one of the largest biologics manufacturing workforces in the country.
Johnson & Johnson is planning to invest more than $2 billion to develop a new pharmaceutical manufacturing campus in North Carolina that would allow it to tap into one of the largest biologics manufacturing workforces in the country.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In